These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26254379)

  • 1. Comparison of Neoadjuvant Chemotherapy to Surgery Followed by Adjuvant Chemotherapy in Japanese Patients with Peritoneal Lavage Cytology Positive for Gastric Carcinoma.
    Yamamoto M; Kawano H; Yamaguchi S; Egashira A; Minami K; Taguchi K; Ikeda Y; Morita M; Toh Y; Okamura T
    Anticancer Res; 2015 Sep; 35(9):4859-63. PubMed ID: 26254379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
    Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
    Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology.
    Valletti M; Eshmuminov D; Gnecco N; Gutschow CA; Schneider PM; Lehmann K
    World J Surg Oncol; 2021 Aug; 19(1):245. PubMed ID: 34404403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic re-evaluation of peritoneal lavage cytology in Japanese patients with gastric carcinoma.
    Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Fujiwara M; Ishida T
    Hepatogastroenterology; 2009; 56(89):261-5. PubMed ID: 19453071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination].
    Fujiwara Y; Doki Y; Takiguchi S; Miyata H; Yamazaki M; Nishida T; Monden M
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1923-5. PubMed ID: 18219854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implication of peritoneal cytology in the pancreatic cancer patients who underwent curative resection followed by adjuvant gemcitabine or S-1 chemotherapy.
    Aoyama T; Katayama Y; Murakawa M; Shiozawa M; Morimoto M; Yamamoto N; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    Hepatogastroenterology; 2015; 62(137):200-6. PubMed ID: 25911897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of peritoneal cytology in potentially resectable pancreatic cancer.
    Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
    Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
    Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
    J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
    Ilhan E; Alemdar A; Ureyen O; Bas K
    J Invest Surg; 2017 Oct; 30(5):318-324. PubMed ID: 27806214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
    Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma.
    Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Yagi Y; Matsuda M; Yonemura Y; Baba H
    Ann Surg; 2009 Aug; 250(2):242-6. PubMed ID: 19638909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis.
    Zhang X; Huang H; Yang D; Wang P; Huang X; Hu Z; Zhang Y; Yan R; Zhu Z; Cai Q
    Technol Cancer Res Treat; 2021; 20():15330338211036310. PubMed ID: 34328799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
    Okada K; Fujiwara Y; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2363-5. PubMed ID: 22202383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection.
    Higaki E; Yanagi S; Gotohda N; Kinoshita T; Kuwata T; Nagino M; Ochiai A; Fujii S
    Cancer Sci; 2017 May; 108(5):978-986. PubMed ID: 28256061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
    Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
    Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
    Nakayama I; Chin K; Matsushima T; Takahari D; Ogura M; Shinozaki E; Suenaga M; Ozaka M; Wakatsuki T; Ichimura T; Hiroki O; Yamaguchi K
    Int J Clin Oncol; 2017 Dec; 22(6):1060-1068. PubMed ID: 28748355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment strategy for type 4 gastric cancer with positive lavage cytology--a decision making of the therapeutic strategy by the change of the result of the lavage cytology].
    Nunobe S; Iwasaki Y; Ohashi M; Shirou I; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1952-4. PubMed ID: 18219862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
    Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
    BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.